Test ID LBOR0174 PharmGx Panel
Useful For
Uses for Test:
- To identify genotypes shown to have a drug-gene variant relationship.
AKA
Warfarin, Plavix, Codeine, Clopidogrel, CYP2C9, CYP2C19, CYP2D6, CYP4F2, IFNL3, CYP2C Cluster
Specimen Type/Requirements
Lavender top (EDTA) tube - Whole Blood
Blood samples will not be accepted for patients that have undergone an allogenic transplant (e.g. bone marrow or peripheral stem cell) OR that have a history of chronic lymphocytic leukemia (CLL).
Transfusion patients: Wait at least 2 weeks after a packed cell/platelet transfusion, and at least 4 weeks after a whole blood transfusion prior to blood draw for testing.
Chemotherapy patients: DNA quality may be affected if patient has received chemotherapy within the last 120 days. Clients will be contacted to provide additional specimen if DNA quality is insufficient.
All specimens should be sent in the original container and should not be aliquoted to another tube. In addition, the specimen submitted should ONLY be used for this testing and should not be shared with any other testing that would also utilize this specimen type.
Testing is not affected by hemolysis or lipemia.
Specimen Volume
Preferred Volume | 2.0 - 4.0 mL |
---|---|
Minimum Volume | 1.0 mL |
Stability/Transport
Room Temperature | 72 hours | |
---|---|---|
Refrigerated | 7 days | Preferred for transport |
Frozen | Not Acceptable |
Performed Test Frequency
Monday through Friday
Report Available
5 - 7 days
Additional Information
The following 11 genes are included in this panel:
- CYP2C9
- VKORC1
- SLCO1B1
- TPMT
- DPYD
- CYP2C19
- CYP3A5
- CYP2D6
- CYP4F2
- IFNL3
- CYP2C Cluster
See Pharmacogenomic Panel Testing for additional information.
Methodology
Allele-specific PCR
Performing Lab
Sanford Medical Genetics Laboratory - Sioux Falls
CPT
81418